Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
about
Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEFThe Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in Stenotrophomonas maltophiliaBacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance DeterminantsMultidrug Efflux Pumps at the Crossroad between Antibiotic Resistance and Bacterial VirulenceEfflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in BrazilPhylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice.Important Role of a Putative Lytic Transglycosylase Cj0843c in β-Lactam Resistance in Campylobacter jejuni.RND multidrug efflux pumps: what are they good for?Mechanisms of resistance in bacteria: an evolutionary approachEfficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection.Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems.Genome Dynamics and Molecular Infection Epidemiology of Multidrug-Resistant Helicobacter pullorum Isolates Obtained from Broiler and Free-Range Chickens in India.Stenotrophomonas maltophilia drug resistance.Metabolic regulation of antibiotic resistance.The antibiotic resistome: challenge and opportunity for therapeutic intervention.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.The intrinsic resistome of bacterial pathogens.Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention.Epistasis and the Evolution of Antimicrobial Resistance.Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations.Quinolone resistance: much more than predicted.Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.Are nonlethal targets useful for developing novel antimicrobials?Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Mechanism of action of and resistance to quinolones
P2860
Q24642435-79E83B41-20DB-4BE2-8290-C452E3BFD026Q27670726-8E6D59DB-4E82-4534-ADF6-606213C85183Q28073636-724B8106-1D64-49B5-8427-5883D181B0DCQ28077689-DBCE87F0-8F2A-4AA3-B789-5AB6D0435BBAQ33655586-80424396-83B8-4C8B-BA56-1A24DA694DFDQ35018772-F7FD0DCB-5EA8-42CC-9598-8AF7F52BDA36Q35860730-F64B2234-C9B4-478B-8763-3E9F66F251ACQ36586658-78281757-E968-4EB3-BBDF-D1AA967D0573Q36733020-22E07FE5-3D1E-4972-87D3-A81B6E3D6415Q37117486-498AB5F2-300B-4626-A152-9184EF26DDA6Q37389801-6E85C325-E82F-4711-92CB-D5F2BE184676Q37512529-957B7214-06DF-4BCB-84B6-4E2984D5E850Q37573751-6ED2D2D9-59F7-4A24-8C99-C2232089C569Q37885402-39D52855-EF49-48E8-A312-F31698EE807FQ37990950-049549DD-BFE2-45F1-AAB5-F729B9BCF3A6Q38011247-0E5D2C0B-A731-4B00-9BF7-13C5EACA836AQ38103861-205B3C44-16AB-49F1-AE02-20E32098A4C9Q38793887-8E318512-C874-4D91-A5CE-1F2858333DF3Q38852902-EA89B7BD-114E-4934-863A-D6259188FA7FQ39162611-D1FF03D9-1D7A-4707-8B3F-A49536D97BBAQ39606842-5F45A3C5-DD9B-4E65-A88E-CD236522E03AQ39737709-F03699D7-EC02-46A7-9134-291260A5173CQ39749477-88A5CEF4-E795-4FF9-B347-7E2BF5235A4AQ51698927-FECD9474-7E3E-4EFD-9702-91DDE1A4E3B1Q52655525-89D572BD-2D28-4F03-910F-DC01719BC363Q58057075-34D81FC9-807A-4DD3-AEC8-CA7999A43BB4
P2860
Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@en
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@nl
type
label
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@en
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@nl
prefLabel
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@en
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@nl
P1433
P1476
Clinical impact of the over-ex ...... ent of efflux pump inhibitors.
@en
P304
P356
10.2174/138945008785747806
P577
2008-09-01T00:00:00Z